SecBot SecBot
Insider Cluster (2 insiders) ·Filed Mar 26, 2026

CGEN

COMPUGEN LTD
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago
Insider cluster: 2 insiders, $37K total
Actionable Insight • Neutral

The insider activity is minor in scale and typical for executives managing option portfolios; no signal of distress or confidence. Monitor upcoming earnings or pipeline updates for material catalysts.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$2.06
T+0 close · Mar 25, 2026 · via day close
Latest settled
+0.97%
T+60 · $2.08
Vs SPY
−12.98%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 26 $2.06entry
  2. T+1 · 8mo ago −0.97%α +0.71% · $2.04
  3. T+5 · 8mo ago +9.71%α +8.08% · $2.26
  4. T+20 · 7mo ago +50.49%α +39.82% · $3.10
  5. T+60 · 5mo ago +0.97%α −12.98% · $2.08
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Compugen CEO Ophir Eran sold $12.4K of stock and exercised two tranches of options, one at zero cost and another at $0.83 per share, while SVP Levine Zurit sold $24K of shares in a recent insider cluster totaling $37K. The sales represent less than 0.1% of the company's $214M market cap and are consistent with routine post-exercise selling.

Key Financial Metrics

Direction
selling
Total Value
$37.0K
Insiders
2

Key Facts

  • CEO Ophir Eran sold 5,625 shares for $12,413 on April 1, 2026, following the exercise of 11,250 options (5,625 at $0, 5,625 at $0.8292).
  • SVP Levine Zurit sold 11,900 shares for $24,000 on March 26, 2026.
  • Total insider selling in the past 7 days: $37,000 across two insiders.
  • All transactions occurred at market prices with no block discounts or unusual timing.

Financial Impact

$37,000 in total open-market sales, representing 0.017% of $214M market cap

insider ownershipshare count

Risk Factors

  • Minimal dilution from option exercises, but economically insignificant.
  • Perception risk if media mischaracterizes zero-cost option exercise as 'selling at $0'.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-CGEN-1775215810179

US Market Status

Market Closed · Opens in 6h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 3, 2026